Parenteral formulations of dopamine agonists Grant US-11045464-B2 United States of America 29 Jun 2021
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment… Grant US-10688155-B2 United States of America 23 Jun 2020
Parenteral formulations of dopamine agonists Grant US-10137132-B2 United States of America 27 Nov 2018
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic… Grant US-9999653-B2 United States of America 19 Jun 2018